Tag: osteosarcoma

Oncotarget News

SETDB1 Amplification Identified as a Potential Target for New Osteosarcoma Treatment

February 14, 2025

Our team has demonstrated the presence of SETDB1 abnormalities, particularly its amplification, through WES analysis of osteosarcoma human samples and cell lines.”BUFFALO, NY - February 14, 2025 – A new review... read more

Oncotarget

The Targeting of WNT5B and WNT10B in Osteosarcoma

September 4, 2024

As there is controversy over whether we should use WNT activators or WNT inhibitors to treat osteosarcoma, we hypothesize that it depends on whether the canonical or non-canonical pathways are... read more

Oncotarget

Oncotarget | Unlocking the Potential of Molecular-Driven Stratification of Osteosarcoma

March 20, 2023

We are very enthusiastic about these initiatives and the recent rate of discoveries in OSA, and hopeful that they will bring actionable targets for OSA.” BUFFALO, NY- March 20,... read more